Substantial evidence indicates that the mutation of tumour necrosis factor α-induced protein 3-interacting protein 1 (TNIP1) may increase the risk of SLE and LN by regulating the canonical NF-κB pathway (19). Here, TNIP1 is linked to systemic lupus erythematosus.